Arkolith/Insider Trading/CEMI/Form 4

Teso-Lichtman Leslie

DirectorCHEMBIO DIAGNOSTICS, INC. (CEMI) · full profile →Form 4 · filed May 1, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 27, 2023Disposed to issuer(D)41K——0
Apr 27, 2023Disposed to issuer(D)96K——0
Apr 27, 2023Disposed to issuer(D)82K——0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-23-022232) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML